Thomas A. Kite, MD, PhD1; Alexander Chase, MD, PhD2; Colum G. Owens, MD 3; Aadil Shaukat, MD4; Abdul M. Mozid, MD5; Peter O’Kane, MD6; Helen Routledge, MD7; Divaka Perera MD, PhD8; Ajay K. Jain, MD9; Nick Palmer, MD10; Stephen P. Hoole, MD11; Mohaned Egred, MD12; Manas K. Sinha, MD13; Thomas J. Cahill, MD, PhD14; Brijesh Anantharam, MD15; Jonathan Byrne, MD16; Paul D. Morris,MD, PhD17; Sharon Kean18; Ahmed Sabra, MD2; Muhammad Aetesam-ur-Rahman, MD1; Jonathan Mailey, MD3; Ozan Demir, MD, PhD8; Kyriacos Mouyis, MD9; Ahmed Abdalwahab, MD12; Dimitrios Terentes-Printzios, MD14; Ritesh Kanyal, MD16; Nick Curzen, MD, PhD19; Colin Berry, MD, PhD20; Anthony H. Gershlick, MD1, Andrew Ladwiniec, MD1; on behalf of the UK-ReVasc Registry Investigators
